XML 53 R38.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
Schedule of Long-lived Assets by Geographic Area

Our long-lived assets (which are comprised of our net property and equipment) by geographic area at December 31, 2021, 2020 and 2019, consisted of the following (in thousands):

    

2021

    

2020

    

2019

United States

$

275,311

$

277,643

$

273,816

Ireland

 

39,863

 

42,951

 

44,912

Other foreign countries

 

56,484

 

62,134

 

60,057

Total

$

371,658

$

382,728

$

378,785

Schedule of Segment Reporting Information, by Segment

Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the years ended December 31, 2021, 2020 and 2019, are as follows (in thousands):

2021

    

2020

    

2019

Net Sales

  

 

  

 

  

Cardiovascular

$

1,043,227

$

934,202

$

960,981

Endoscopy

 

31,524

 

29,673

 

33,871

Total net sales

 

1,074,751

 

963,875

 

994,852

Operating Income (Loss)

 

  

 

  

 

  

Cardiovascular

 

53,415

 

(7,042)

 

25,780

Endoscopy

 

7,501

 

5,480

 

(10,346)

Total operating income (loss)

 

60,916

 

(1,562)

 

15,434

Total other expense - net

 

(6,999)

 

(11,669)

 

(13,241)

Income tax expense (benefit)

 

5,463

 

(3,388)

 

(3,258)

Net income (loss)

$

48,454

$

(9,843)

$

5,451

Total depreciation and amortization by operating segment for the years ended December 31, 2021, 2020 and 2019, consisted of the following (in thousands):

    

2021

    

2020

    

2019

Cardiovascular

$

83,000

$

93,160

$

91,151

Endoscopy

 

1,066

 

910

 

949

Total

$

84,066

$

94,070

$

92,100

Total capital expenditures for property and equipment by operating segment for the years ended December 31, 2021, 2020 and 2019, consisted of the following (in thousands):

    

2021

    

2020

    

2019

Cardiovascular

$

27,557

$

45,803

$

77,631

Endoscopy

 

382

 

185

 

542

Total

$

27,939

$

45,988

$

78,173

Reconciliation of Assets from Segment to Consolidated

2021

    

2020

    

2019

Net Sales

  

 

  

 

  

Cardiovascular

$

1,043,227

$

934,202

$

960,981

Endoscopy

 

31,524

 

29,673

 

33,871

Total net sales

 

1,074,751

 

963,875

 

994,852

Operating Income (Loss)

 

  

 

  

 

  

Cardiovascular

 

53,415

 

(7,042)

 

25,780

Endoscopy

 

7,501

 

5,480

 

(10,346)

Total operating income (loss)

 

60,916

 

(1,562)

 

15,434

Total other expense - net

 

(6,999)

 

(11,669)

 

(13,241)

Income tax expense (benefit)

 

5,463

 

(3,388)

 

(3,258)

Net income (loss)

$

48,454

$

(9,843)

$

5,451